Manju Vaiyapuri
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Manju Vaiyapuri has a total of 62 co-authors. Here are the top co-authors by number of shared publications:
- Karthi Natesan
Crop Protection Division Rural Development Administration National Institute of Agricultural Sciences 55365 Wanju Korea
8 shared publications - Mariyappan Palani
Molecular Oncology Lab, Department of Biochemistry, Periyar University, Salem, Tamil Nadu, 636 011, India
5 shared publications Kalaiyarasu Thangaraj
Department of Microbiology and Biotechnology, Bharath Institute of Higher Education and Research, Chennai, Tamil Nadu, India
4 shared publications- Mydhili Govindarasu
Molecular Oncology Laboratory, Department of Biochemistry, Periyar University, Salem 636011, Tamil Nadu, India
3 shared publications N. Nalini
3 shared publications- Namasivayam Nalini
Department of Biochemistry and Biotechnology, Faculty of Science, Annamalai University, Annamalainagar 608 002, Tamilnadu, India
3 shared publications
Latest Publications
- 12 January 2022
- Published by Wiley in Biotechnology and Applied Biochemistry
- Vol. 69 (6) , 2387-2398
Synthesis, physicochemical characterization, and in vitro evaluation of biodegradable PLGA nanoparticles entrapped to folic acid for targeted delivery of kaempferitrin
Polymeric nanoparticles are widely studied in the treatment of colorectal cancer. Kaempferitrin‐loaded nontoxic and biodegradable poly(d,l‐lactic‐co‐glycolic acid) (PLGA) nanoparticles (NPs) developed by the solvent emulsion evaporation method by improving its solubility and bioavailability. In order to improve the delivery of kaempferitrin (KM) to cancerous cells, folic acid (FA) combined kaempfertrin PLGA NPs were prepared. The goal of the study was whether PLGA NPs with surface KM and FA could help to prevent colorectal cancer. The synthesis of KM with FA in a nanomedicine could be crucial in the development of colon cancer chemotherapeutics. The physicochemical characteristics of synthesized KM‐entrapped PLGA NPs were investigated by XRD, FTIR, zeta potential, and TEM. The KM + FA + PLGA NPs showed particle size with 132.9 ± 1.4 nm, zeta potential ‒15.0 ± 1.73 mV, encapsulation efficiency 67.92 ± 4.8, and drug‐loading capacity 0.463 ± 0.173. In vitro cytotoxicity study on HT‒29 cell lines using the MTT assay, the apoptotic study revealed that KM + FA + PLGA NPs have an enhanced cytotoxic effect compared to the KM + PLGA NPs drug solution. These findings suggested that KM + FA + PLGA NPs could be an effective chemotherapeutic drug delivery system in colon adenocarcinoma HT‐29 cells.
- 12 January 2022
- Published by Wiley in Biotechnology and Applied Biochemistry
- Vol. 69 (6) , 2387-2398
Synthesis, physicochemical characterization, and in vitro evaluation of biodegradable PLGA nanoparticles entrapped to folic acid for targeted delivery of kaempferitrin
Polymeric nanoparticles are widely studied in the treatment of colorectal cancer. Kaempferitrin‐loaded nontoxic and biodegradable poly(d,l‐lactic‐co‐glycolic acid) (PLGA) nanoparticles (NPs) developed by the solvent emulsion evaporation method by improving its solubility and bioavailability. In order to improve the delivery of kaempferitrin (KM) to cancerous cells, folic acid (FA) combined kaempfertrin PLGA NPs were prepared. The goal of the study was whether PLGA NPs with surface KM and FA could help to prevent colorectal cancer. The synthesis of KM with FA in a nanomedicine could be crucial in the development of colon cancer chemotherapeutics. The physicochemical characteristics of synthesized KM‐entrapped PLGA NPs were investigated by XRD, FTIR, zeta potential, and TEM. The KM + FA + PLGA NPs showed particle size with 132.9 ± 1.4 nm, zeta potential ‒15.0 ± 1.73 mV, encapsulation efficiency 67.92 ± 4.8, and drug‐loading capacity 0.463 ± 0.173. In vitro cytotoxicity study on HT‒29 cell lines using the MTT assay, the apoptotic study revealed that KM + FA + PLGA NPs have an enhanced cytotoxic effect compared to the KM + PLGA NPs drug solution. These findings suggested that KM + FA + PLGA NPs could be an effective chemotherapeutic drug delivery system in colon adenocarcinoma HT‐29 cells.
- Open Access
Protective Effect of Salvianolic Acid B in Acetic Acid-Induced Experimental Colitis in a Mouse Model
In its prominent experimental studies salvianolic acid B (Sal B) is novel because of its well-defined, common physiological effects, which include anti-inflammatory, anti-depressant, cardioprotective, DNA protective, neuroprotective and hepatoprotective activity in experimental animals. Initially, Sal B was studied for its anti-inflammatory properties, used as a remedy for a wide range of disease conditions, but its specific efficacy on inflammatory bowel disease is still unclear. The aim of this current study was to understand the therapeutic potential of Sal B in an acetic acid (AA)—triggered experimental mouse colitis model. Colitis was triggered by intrarectal injection of 5% AA, and then laboratory animals were given Sal B (10, 20 and 40 μg/kg) for seven days. The ulcerated colonic mucosa was assessed by clinical experiment, macroscopical, biological and histopathological analysis. The results showed depleted SOD, CAT, GSH levels and consequential elevated MPO and MDA levels and aberrant crypt foci and mast cells were seen in the AA-induced colonic mucosa of experimental animals. The data obtained from this study demonstrate that a dose of 40 µg/kg showed an efficacious anti-ulcer effect against AA-induced experimental colitis. Based on its antioxidant efficacy, Sal B may therefore be useful as a therapeutic approach for ulcerative colitis.
Open AccessProtective Effect of Salvianolic Acid B in Acetic Acid-Induced Experimental Colitis in a Mouse Model
In its prominent experimental studies salvianolic acid B (Sal B) is novel because of its well-defined, common physiological effects, which include anti-inflammatory, anti-depressant, cardioprotective, DNA protective, neuroprotective and hepatoprotective activity in experimental animals. Initially, Sal B was studied for its anti-inflammatory properties, used as a remedy for a wide range of disease conditions, but its specific efficacy on inflammatory bowel disease is still unclear. The aim of this current study was to understand the therapeutic potential of Sal B in an acetic acid (AA)—triggered experimental mouse colitis model. Colitis was triggered by intrarectal injection of 5% AA, and then laboratory animals were given Sal B (10, 20 and 40 μg/kg) for seven days. The ulcerated colonic mucosa was assessed by clinical experiment, macroscopical, biological and histopathological analysis. The results showed depleted SOD, CAT, GSH levels and consequential elevated MPO and MDA levels and aberrant crypt foci and mast cells were seen in the AA-induced colonic mucosa of experimental animals. The data obtained from this study demonstrate that a dose of 40 µg/kg showed an efficacious anti-ulcer effect against AA-induced experimental colitis. Based on its antioxidant efficacy, Sal B may therefore be useful as a therapeutic approach for ulcerative colitis.
- 20 August 2021
- Published by Springer Nature in Journal of Cluster Science
- Vol. 33 (2) , 825-834
Evaluation of the Antioxidant, Antimicrobial, Haemolytic and Cytotoxic Effect of Eggshell Based Hydroxyapatite
- 20 August 2021
- Published by Springer Nature in Journal of Cluster Science
- Vol. 33 (2) , 825-834
Evaluation of the Antioxidant, Antimicrobial, Haemolytic and Cytotoxic Effect of Eggshell Based Hydroxyapatite
- 23 July 2021
- Published by Taylor & Francis in Inorganic and Nano-Metal Chemistry
- Vol. 52 (6) , 809-818
Green synthesis of copper oxide nanoparticles using Euphorbia hirta leaves extract and its biological applications
The synthesis of metal nanoparticles by a green method is eco-friendly, nontoxic and few benefits to the growing fields of research used inhibit bacteria and cancer growth over the recent years. In this study, CuO NPs are synthesized through Euphorbia hirta leaf extract. Formation of CuO NPs was confirmed by SPR peak at UV spectrum. FTIR identified functional groups are responsible for reduction and stabilization, GC–MS, phytochemicals present in the Euphorbia hirta extract accountable for synthesizing CuO NPs. XRD confirmed crystalline nature, SEM and TEM confirmed size and spherical morphology. Furthermore, CuO NPs effective antibacterial activity to inhibit pathogens, strong biological activities regarding antioxidant activity and anti-inflammatory activity and excellent anticancer activity against the Ht-29 cell line. Also, good catalyst for the effective degradation of methylene blue. The present study suggests that biosynthesized CuO NPs through an extract from Euphorbia hirta may be used for therapeutic application in future clinical studies.
- 23 July 2021
- Published by Taylor & Francis in Inorganic and Nano-Metal Chemistry
- Vol. 52 (6) , 809-818
Green synthesis of copper oxide nanoparticles using Euphorbia hirta leaves extract and its biological applications
The synthesis of metal nanoparticles by a green method is eco-friendly, nontoxic and few benefits to the growing fields of research used inhibit bacteria and cancer growth over the recent years. In this study, CuO NPs are synthesized through Euphorbia hirta leaf extract. Formation of CuO NPs was confirmed by SPR peak at UV spectrum. FTIR identified functional groups are responsible for reduction and stabilization, GC–MS, phytochemicals present in the Euphorbia hirta extract accountable for synthesizing CuO NPs. XRD confirmed crystalline nature, SEM and TEM confirmed size and spherical morphology. Furthermore, CuO NPs effective antibacterial activity to inhibit pathogens, strong biological activities regarding antioxidant activity and anti-inflammatory activity and excellent anticancer activity against the Ht-29 cell line. Also, good catalyst for the effective degradation of methylene blue. The present study suggests that biosynthesized CuO NPs through an extract from Euphorbia hirta may be used for therapeutic application in future clinical studies.
- 28 June 2020
- Published by Springer Nature
- p. 119-135
Pelargonidin, a Dietary Anthocyanidin in the Prevention of Colorectal Cancer and Its Chemoprotective Mechanisms
- 28 June 2020
- Published by Springer Nature
- p. 119-135
Pelargonidin, a Dietary Anthocyanidin in the Prevention of Colorectal Cancer and Its Chemoprotective Mechanisms
- 28 June 2020
- Published by Springer Nature
- p. 1-19
Orientin: A C-Glycosyl Flavonoid that Mitigates Colorectal Cancer
- 28 June 2020
- Published by Springer Nature
- p. 1-19
Orientin: A C-Glycosyl Flavonoid that Mitigates Colorectal Cancer
- Open Access
- 27 August 2019
- Published by MDPI AG in Biomolecules
- Vol. 9 (9) , 418
Orientin Induces G0/G1 Cell Cycle Arrest and Mitochondria Mediated Intrinsic Apoptosis in Human Colorectal Carcinoma HT29 Cells
Colorectal carcinoma is one of the utmost diagnosed cancer with a steep increase in mortality rate. The incidence has been increasing in developing countries like India due to a westernization life style. Flavonoids have been explored widely for its various pharmacological activity including antitumor activity. Orientin, an analogue of luteolin (citrus flavonoid) isolated from rooibos and tulsi leaves is also expected to deliver significant antitumor activity similar to that of luteolin. The present study anticipates exploring the antitumor activity of orientin against colorectal carcinoma cells (HT29). Orientin exhibited remarkable cytotoxicity and antiproliferative activity against HT29 cells, which is clearly evident from tetrazolium based cytotoxicity and lactate dehydrogenase release assays. Orientin induce G0/G1 cell cycle arrest and regulates cyclin and cyclin-dependent protein kinases in order to prevent the entry of the cell cycle to the S phase. Annexin V-FITC (V-Fluorescein Isothiocyanate) dual staining reveals the apoptotic induction ability of orientin. The Bcl-2 family proteins along with the inhibitor of apoptotic proteins were regulated and the tumor suppressor p-53 expression have been decreased. In conclusion, our results proposed that orientin could be a potent chemotherapeutic agent against colorectal cancer after ascertaining their molecular mechanisms.
- 27 August 2019
- Published by MDPI AG in Biomolecules
- Vol. 9 (9) , 418
Open AccessOrientin Induces G0/G1 Cell Cycle Arrest and Mitochondria Mediated Intrinsic Apoptosis in Human Colorectal Carcinoma HT29 Cells
Colorectal carcinoma is one of the utmost diagnosed cancer with a steep increase in mortality rate. The incidence has been increasing in developing countries like India due to a westernization life style. Flavonoids have been explored widely for its various pharmacological activity including antitumor activity. Orientin, an analogue of luteolin (citrus flavonoid) isolated from rooibos and tulsi leaves is also expected to deliver significant antitumor activity similar to that of luteolin. The present study anticipates exploring the antitumor activity of orientin against colorectal carcinoma cells (HT29). Orientin exhibited remarkable cytotoxicity and antiproliferative activity against HT29 cells, which is clearly evident from tetrazolium based cytotoxicity and lactate dehydrogenase release assays. Orientin induce G0/G1 cell cycle arrest and regulates cyclin and cyclin-dependent protein kinases in order to prevent the entry of the cell cycle to the S phase. Annexin V-FITC (V-Fluorescein Isothiocyanate) dual staining reveals the apoptotic induction ability of orientin. The Bcl-2 family proteins along with the inhibitor of apoptotic proteins were regulated and the tumor suppressor p-53 expression have been decreased. In conclusion, our results proposed that orientin could be a potent chemotherapeutic agent against colorectal cancer after ascertaining their molecular mechanisms.
- 1 October 2018
- Published by Wolters Kluwer Health in Journal of Cancer Research and Therapeutics
- Vol. 14 (6) , 1379-1388
Orientin mitigates 1, 2-dimethylhydrazine induced lipid peroxidation, antioxidant and biotransforming bacterial enzyme alterations in experimental rats
Background: Colorectal cancer (CRC) is the second most diagnosed cancer often identified during the later stages of carcinogenesis. Orientin, a C -glycoside of luteolin, is well known for its versatile therapeutic action toward oxidative stress-induced cellular response may exert chemoprevention against CRC. Materials and Methods: In our study, we investigated the modulatory effect of orientin on lipid peroxidation, antioxidant defense, and biotransforming bacterial enzymes in 1, 2-dimethylhydrazine (DMH)-induced male albino Wistar rats in a dose-dependent manner. Animals were induced with DMH (20 mg/kg b.wt) for 15 weeks and administered with orientin in three different doses (5 mg/kg, 10 mg/kg, and 20 mg/kg b. wt) daily under distinct phases (initiation, postinitiation, and the entire) for a total treatment period of 30 weeks. Results: Orientin reinstates the alterations induced by DMH on lipid peroxidation and enzymatic antioxidants through its rich-free radical scavenging properties. In addition, orientin curtails the DMH-induced augmentation of biotransforming bacterial enzymes to inhibit the colon cancer progression. Overall, experimental findings suggest that orientin significantly inhibits the DMH induced colon cancer in all the three different doses, however, maximum inhibition was observed on supplementation of 10 mg/kg b.wt for the entire period of the study. Conclusion: Hence, the intraperitoneal administration of 10 mg/kg b.wt orientin for the entire period is recommended for further molecular investigation to elucidate the precise mechanism of inhibition and so orientin can be used as a novel chemotherapeutic agent for CRC.
- 1 October 2018
- Published by Wolters Kluwer Health in Journal of Cancer Research and Therapeutics
- Vol. 14 (6) , 1379-1388
Orientin mitigates 1, 2-dimethylhydrazine induced lipid peroxidation, antioxidant and biotransforming bacterial enzyme alterations in experimental rats
Background: Colorectal cancer (CRC) is the second most diagnosed cancer often identified during the later stages of carcinogenesis. Orientin, a C -glycoside of luteolin, is well known for its versatile therapeutic action toward oxidative stress-induced cellular response may exert chemoprevention against CRC. Materials and Methods: In our study, we investigated the modulatory effect of orientin on lipid peroxidation, antioxidant defense, and biotransforming bacterial enzymes in 1, 2-dimethylhydrazine (DMH)-induced male albino Wistar rats in a dose-dependent manner. Animals were induced with DMH (20 mg/kg b.wt) for 15 weeks and administered with orientin in three different doses (5 mg/kg, 10 mg/kg, and 20 mg/kg b. wt) daily under distinct phases (initiation, postinitiation, and the entire) for a total treatment period of 30 weeks. Results: Orientin reinstates the alterations induced by DMH on lipid peroxidation and enzymatic antioxidants through its rich-free radical scavenging properties. In addition, orientin curtails the DMH-induced augmentation of biotransforming bacterial enzymes to inhibit the colon cancer progression. Overall, experimental findings suggest that orientin significantly inhibits the DMH induced colon cancer in all the three different doses, however, maximum inhibition was observed on supplementation of 10 mg/kg b.wt for the entire period of the study. Conclusion: Hence, the intraperitoneal administration of 10 mg/kg b.wt orientin for the entire period is recommended for further molecular investigation to elucidate the precise mechanism of inhibition and so orientin can be used as a novel chemotherapeutic agent for CRC.
- Open Access
- 1 January 2018
- Published by Elsevier in Toxicology Reports
- Vol. 5, 977-987
Orientin, a flavanoid, mitigates 1, 2 dimethylhydrazine-induced colorectal lesions in Wistar rats fed a high-fat diet
- 1 January 2018
- Published by Elsevier in Toxicology Reports
- Vol. 5, 977-987
Open AccessOrientin, a flavanoid, mitigates 1, 2 dimethylhydrazine-induced colorectal lesions in Wistar rats fed a high-fat diet